A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PATZ1 | hg19_v2_chr22_-_31742218_31742350 | 0.96 | 2.1e-03 | Click! |
KLF4 | hg19_v2_chr9_-_110251836_110251927 | 0.54 | 2.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_220252603 | 7.23 |
ENST00000322176.7
ENST00000273075.4 |
DNPEP
|
aspartyl aminopeptidase |
chr2_+_74212073 | 6.80 |
ENST00000441217.1
|
AC073046.25
|
AC073046.25 |
chrX_-_1331527 | 6.27 |
ENST00000381567.3
ENST00000381566.1 ENST00000400841.2 |
CRLF2
|
cytokine receptor-like factor 2 |
chr2_-_220252530 | 5.64 |
ENST00000521459.1
|
DNPEP
|
aspartyl aminopeptidase |
chr19_-_38878632 | 5.11 |
ENST00000586599.1
ENST00000334928.6 ENST00000587676.1 |
GGN
|
gametogenetin |
chr7_+_97910962 | 4.90 |
ENST00000539286.1
|
BRI3
|
brain protein I3 |
chr2_+_20866424 | 4.63 |
ENST00000272224.3
|
GDF7
|
growth differentiation factor 7 |
chr9_+_139971921 | 4.60 |
ENST00000409858.3
|
UAP1L1
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
chr12_+_132379160 | 4.16 |
ENST00000321867.4
|
ULK1
|
unc-51 like autophagy activating kinase 1 |
chr1_+_11333546 | 4.15 |
ENST00000376804.2
|
UBIAD1
|
UbiA prenyltransferase domain containing 1 |
chr8_+_1711918 | 3.94 |
ENST00000331222.4
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
chr12_+_104235229 | 3.92 |
ENST00000551650.1
|
RP11-650K20.3
|
Uncharacterized protein |
chr17_+_79008940 | 3.92 |
ENST00000392411.3
ENST00000575989.1 ENST00000321280.7 ENST00000428708.2 ENST00000575712.1 ENST00000575245.1 ENST00000435091.3 ENST00000321300.6 |
BAIAP2
|
BAI1-associated protein 2 |
chr1_-_15850676 | 3.92 |
ENST00000440484.1
ENST00000333868.5 |
CASP9
|
caspase 9, apoptosis-related cysteine peptidase |
chr1_+_228362251 | 3.91 |
ENST00000546123.1
|
IBA57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
chr16_+_32264645 | 3.85 |
ENST00000569631.1
ENST00000354614.3 |
TP53TG3D
|
TP53 target 3D |
chr21_+_44394742 | 3.82 |
ENST00000432907.2
|
PKNOX1
|
PBX/knotted 1 homeobox 1 |
chrX_-_16888276 | 3.76 |
ENST00000493145.1
|
RBBP7
|
retinoblastoma binding protein 7 |
chr11_-_64949305 | 3.73 |
ENST00000526623.1
|
AP003068.23
|
Uncharacterized protein |
chr8_-_145691031 | 3.73 |
ENST00000424149.2
ENST00000530637.1 ENST00000306145.5 |
CYHR1
|
cysteine/histidine-rich 1 |
chr12_-_58145889 | 3.69 |
ENST00000547853.1
|
CDK4
|
cyclin-dependent kinase 4 |
chr14_-_100625932 | 3.68 |
ENST00000553834.1
|
DEGS2
|
delta(4)-desaturase, sphingolipid 2 |
chr1_-_21948906 | 3.60 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr4_+_1714548 | 3.58 |
ENST00000605571.1
|
RP11-572O17.1
|
RP11-572O17.1 |
chr19_-_9929708 | 3.57 |
ENST00000247977.4
ENST00000590277.1 ENST00000588922.1 ENST00000589626.1 ENST00000592067.1 ENST00000586469.1 |
FBXL12
|
F-box and leucine-rich repeat protein 12 |
chr11_-_17410629 | 3.54 |
ENST00000526912.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
chr6_-_41747595 | 3.54 |
ENST00000373018.3
|
FRS3
|
fibroblast growth factor receptor substrate 3 |
chr16_-_11350036 | 3.48 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
chr16_+_84002234 | 3.44 |
ENST00000305202.4
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2 |
chr14_-_21566731 | 3.40 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
chr18_+_11981547 | 3.36 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr19_+_51815102 | 3.34 |
ENST00000270642.8
|
IGLON5
|
IgLON family member 5 |
chr16_+_88519669 | 3.33 |
ENST00000319555.3
|
ZFPM1
|
zinc finger protein, FOG family member 1 |
chr12_+_133066137 | 3.31 |
ENST00000434748.2
|
FBRSL1
|
fibrosin-like 1 |
chr18_+_11981014 | 3.31 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr17_-_67323385 | 3.25 |
ENST00000588665.1
|
ABCA5
|
ATP-binding cassette, sub-family A (ABC1), member 5 |
chr19_+_38879061 | 3.23 |
ENST00000587013.1
|
SPRED3
|
sprouty-related, EVH1 domain containing 3 |
chr3_-_126076264 | 3.13 |
ENST00000296233.3
|
KLF15
|
Kruppel-like factor 15 |
chr7_+_33168856 | 3.12 |
ENST00000432983.1
|
BBS9
|
Bardet-Biedl syndrome 9 |
chr15_+_65134088 | 3.11 |
ENST00000323544.4
ENST00000437723.1 |
PLEKHO2
AC069368.3
|
pleckstrin homology domain containing, family O member 2 Uncharacterized protein |
chr5_-_176738883 | 3.07 |
ENST00000513169.1
ENST00000423571.2 ENST00000502529.1 ENST00000427908.2 |
MXD3
|
MAX dimerization protein 3 |
chr19_-_14201776 | 3.06 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr19_+_50433476 | 3.03 |
ENST00000596658.1
|
ATF5
|
activating transcription factor 5 |
chr8_+_144371773 | 3.01 |
ENST00000523891.1
|
ZNF696
|
zinc finger protein 696 |
chr20_-_61051026 | 3.00 |
ENST00000252997.2
|
GATA5
|
GATA binding protein 5 |
chr4_+_2794750 | 2.99 |
ENST00000452765.2
ENST00000389838.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr8_-_145690724 | 2.96 |
ENST00000526887.1
ENST00000533764.1 ENST00000403000.2 |
CYHR1
|
cysteine/histidine-rich 1 |
chr2_-_240322685 | 2.95 |
ENST00000544989.1
|
HDAC4
|
histone deacetylase 4 |
chr17_+_79935418 | 2.92 |
ENST00000306729.7
ENST00000306739.4 |
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
chr17_-_72869086 | 2.90 |
ENST00000581530.1
ENST00000420580.2 ENST00000455107.2 ENST00000413947.2 ENST00000581219.1 ENST00000582944.1 |
FDXR
|
ferredoxin reductase |
chr19_-_48673580 | 2.90 |
ENST00000427526.2
|
LIG1
|
ligase I, DNA, ATP-dependent |
chr9_+_139377947 | 2.89 |
ENST00000354376.1
|
C9orf163
|
chromosome 9 open reading frame 163 |
chr19_+_41305330 | 2.84 |
ENST00000593972.1
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2 |
chr9_+_140500126 | 2.82 |
ENST00000431925.2
ENST00000419386.1 |
ARRDC1
|
arrestin domain containing 1 |
chr19_+_56111680 | 2.81 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
chr7_+_36192758 | 2.79 |
ENST00000242108.4
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
chr20_+_42295745 | 2.78 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr11_+_64073022 | 2.77 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
chr15_-_82338460 | 2.76 |
ENST00000558133.1
ENST00000329713.4 |
MEX3B
|
mex-3 RNA binding family member B |
chr19_-_2096478 | 2.76 |
ENST00000591236.1
ENST00000589902.1 |
MOB3A
|
MOB kinase activator 3A |
chr19_+_36266417 | 2.76 |
ENST00000378944.5
ENST00000007510.4 |
ARHGAP33
|
Rho GTPase activating protein 33 |
chr18_+_77794446 | 2.75 |
ENST00000262197.7
|
RBFA
|
ribosome binding factor A (putative) |
chr21_-_47648665 | 2.73 |
ENST00000450351.1
ENST00000522411.1 ENST00000356396.4 ENST00000397728.3 ENST00000457828.2 |
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
chr20_+_62369623 | 2.73 |
ENST00000467211.1
|
RP4-583P15.14
|
RP4-583P15.14 |
chr19_-_48673552 | 2.73 |
ENST00000536218.1
ENST00000596549.1 |
LIG1
|
ligase I, DNA, ATP-dependent |
chr22_-_43583079 | 2.72 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr11_-_67397371 | 2.68 |
ENST00000376693.2
ENST00000301490.4 |
NUDT8
|
nudix (nucleoside diphosphate linked moiety X)-type motif 8 |
chr17_-_42277203 | 2.67 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr12_-_57914275 | 2.64 |
ENST00000547303.1
ENST00000552740.1 ENST00000547526.1 ENST00000551116.1 ENST00000346473.3 |
DDIT3
|
DNA-damage-inducible transcript 3 |
chr17_+_7155343 | 2.62 |
ENST00000573513.1
ENST00000354429.2 ENST00000574255.1 ENST00000396627.2 ENST00000356683.2 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
chr20_+_388791 | 2.61 |
ENST00000441733.1
ENST00000353660.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr16_-_88752889 | 2.56 |
ENST00000332281.5
|
SNAI3
|
snail family zinc finger 3 |
chr12_+_57914481 | 2.55 |
ENST00000548887.1
|
MBD6
|
methyl-CpG binding domain protein 6 |
chr17_-_72869140 | 2.55 |
ENST00000583917.1
ENST00000293195.5 ENST00000442102.2 |
FDXR
|
ferredoxin reductase |
chr16_-_402639 | 2.53 |
ENST00000262320.3
|
AXIN1
|
axin 1 |
chr2_-_132589601 | 2.52 |
ENST00000437330.1
|
AC103564.7
|
AC103564.7 |
chr20_+_1206679 | 2.51 |
ENST00000402452.1
ENST00000409241.1 ENST00000381882.2 ENST00000246108.3 |
RAD21L1
|
RAD21-like 1 (S. pombe) |
chr19_-_4457776 | 2.51 |
ENST00000301281.6
|
UBXN6
|
UBX domain protein 6 |
chr19_-_49522727 | 2.50 |
ENST00000600007.1
|
CTB-60B18.10
|
CTB-60B18.10 |
chr4_+_3076388 | 2.50 |
ENST00000355072.5
|
HTT
|
huntingtin |
chr1_+_1260598 | 2.47 |
ENST00000488011.1
|
GLTPD1
|
glycolipid transfer protein domain containing 1 |
chr19_-_6767431 | 2.46 |
ENST00000437152.3
ENST00000597687.1 |
SH2D3A
|
SH2 domain containing 3A |
chr22_+_38004832 | 2.44 |
ENST00000405147.3
ENST00000429218.1 ENST00000325180.8 ENST00000337437.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr11_-_45928830 | 2.42 |
ENST00000449465.1
|
C11orf94
|
chromosome 11 open reading frame 94 |
chr19_-_10047219 | 2.41 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
chr11_-_65686496 | 2.40 |
ENST00000449692.3
|
C11orf68
|
chromosome 11 open reading frame 68 |
chr1_-_38471156 | 2.40 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
chr7_+_36192855 | 2.40 |
ENST00000534978.1
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
chr9_-_139891165 | 2.39 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
chr16_+_89894875 | 2.38 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
chr12_+_57916466 | 2.35 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
chr7_-_72992865 | 2.34 |
ENST00000452475.1
|
TBL2
|
transducin (beta)-like 2 |
chrX_-_149106653 | 2.34 |
ENST00000462691.1
ENST00000370404.1 ENST00000483447.1 ENST00000370409.3 |
CXorf40B
|
chromosome X open reading frame 40B |
chr16_-_89768035 | 2.34 |
ENST00000569918.1
|
SPATA2L
|
spermatogenesis associated 2-like |
chr20_-_19738569 | 2.33 |
ENST00000598007.1
|
AL121761.2
|
Uncharacterized protein |
chr17_-_42200996 | 2.33 |
ENST00000587135.1
ENST00000225983.6 ENST00000393622.2 ENST00000588703.1 |
HDAC5
|
histone deacetylase 5 |
chr11_+_64002292 | 2.33 |
ENST00000426086.2
|
VEGFB
|
vascular endothelial growth factor B |
chr11_-_65686586 | 2.33 |
ENST00000438576.2
|
C11orf68
|
chromosome 11 open reading frame 68 |
chr12_-_123450986 | 2.32 |
ENST00000344275.7
ENST00000442833.2 ENST00000280560.8 ENST00000540285.1 ENST00000346530.5 |
ABCB9
|
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
chr22_-_39548627 | 2.30 |
ENST00000216133.5
|
CBX7
|
chromobox homolog 7 |
chr8_-_144679602 | 2.30 |
ENST00000526710.1
|
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
chr15_+_42120283 | 2.29 |
ENST00000542534.2
ENST00000397299.4 ENST00000408047.1 ENST00000431823.1 ENST00000382448.4 ENST00000342159.4 |
PLA2G4B
JMJD7
JMJD7-PLA2G4B
|
phospholipase A2, group IVB (cytosolic) jumonji domain containing 7 JMJD7-PLA2G4B readthrough |
chr3_-_52443799 | 2.29 |
ENST00000470173.1
ENST00000296288.5 |
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
chr8_-_1922789 | 2.27 |
ENST00000521498.1
|
RP11-439C15.4
|
RP11-439C15.4 |
chr6_-_30654977 | 2.27 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr1_-_3528034 | 2.26 |
ENST00000356575.4
|
MEGF6
|
multiple EGF-like-domains 6 |
chr16_-_776846 | 2.25 |
ENST00000423653.1
|
CCDC78
|
coiled-coil domain containing 78 |
chr9_+_140500087 | 2.25 |
ENST00000371421.4
|
ARRDC1
|
arrestin domain containing 1 |
chr12_+_57916584 | 2.25 |
ENST00000546632.1
ENST00000549623.1 ENST00000431731.2 |
MBD6
|
methyl-CpG binding domain protein 6 |
chr12_-_6982442 | 2.25 |
ENST00000523102.1
ENST00000524270.1 ENST00000519357.1 |
SPSB2
|
splA/ryanodine receptor domain and SOCS box containing 2 |
chr1_-_15850839 | 2.25 |
ENST00000348549.5
ENST00000546424.1 |
CASP9
|
caspase 9, apoptosis-related cysteine peptidase |
chr20_+_388935 | 2.25 |
ENST00000382181.2
ENST00000400247.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr19_-_34012674 | 2.24 |
ENST00000436370.3
ENST00000397032.4 ENST00000244137.7 |
PEPD
|
peptidase D |
chr19_+_54694119 | 2.24 |
ENST00000456872.1
ENST00000302937.4 ENST00000429671.2 |
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
chr3_+_158450143 | 2.23 |
ENST00000491804.1
|
MFSD1
|
major facilitator superfamily domain containing 1 |
chr8_-_144651024 | 2.23 |
ENST00000524906.1
ENST00000532862.1 ENST00000534459.1 |
MROH6
|
maestro heat-like repeat family member 6 |
chr22_-_19165917 | 2.23 |
ENST00000451283.1
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
chr22_-_41842781 | 2.22 |
ENST00000434408.1
|
TOB2
|
transducer of ERBB2, 2 |
chr16_-_89768097 | 2.22 |
ENST00000289805.5
ENST00000335360.7 |
SPATA2L
|
spermatogenesis associated 2-like |
chr11_+_66234216 | 2.22 |
ENST00000349459.6
ENST00000320740.7 ENST00000524466.1 ENST00000526296.1 |
PELI3
|
pellino E3 ubiquitin protein ligase family member 3 |
chr16_+_77246337 | 2.22 |
ENST00000563157.1
|
SYCE1L
|
synaptonemal complex central element protein 1-like |
chr11_+_6411670 | 2.21 |
ENST00000530395.1
ENST00000527275.1 |
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal |
chr19_+_59055814 | 2.21 |
ENST00000594806.1
ENST00000253024.5 ENST00000341753.6 |
TRIM28
|
tripartite motif containing 28 |
chr8_+_144349606 | 2.21 |
ENST00000521682.1
ENST00000340042.1 |
GLI4
|
GLI family zinc finger 4 |
chr7_-_72992663 | 2.21 |
ENST00000432538.1
|
TBL2
|
transducin (beta)-like 2 |
chr11_+_208773 | 2.20 |
ENST00000528357.1
|
RIC8A
|
RIC8 guanine nucleotide exchange factor A |
chr20_+_388679 | 2.19 |
ENST00000356286.5
ENST00000475269.1 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr15_+_76352178 | 2.19 |
ENST00000388942.3
|
C15orf27
|
chromosome 15 open reading frame 27 |
chr12_+_122018697 | 2.19 |
ENST00000541574.1
|
RP13-941N14.1
|
RP13-941N14.1 |
chr22_+_50946645 | 2.19 |
ENST00000420993.2
ENST00000395698.3 ENST00000395701.3 ENST00000523045.1 ENST00000299821.11 |
NCAPH2
|
non-SMC condensin II complex, subunit H2 |
chr2_+_95537248 | 2.19 |
ENST00000427593.2
|
TEKT4
|
tektin 4 |
chr8_-_145016692 | 2.17 |
ENST00000357649.2
|
PLEC
|
plectin |
chr13_-_74708372 | 2.16 |
ENST00000377666.4
|
KLF12
|
Kruppel-like factor 12 |
chrX_-_1572629 | 2.15 |
ENST00000534940.1
|
ASMTL
|
acetylserotonin O-methyltransferase-like |
chr16_+_2564254 | 2.15 |
ENST00000565223.1
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
chr20_+_36531544 | 2.14 |
ENST00000448944.1
|
VSTM2L
|
V-set and transmembrane domain containing 2 like |
chr17_+_72772621 | 2.14 |
ENST00000335464.5
ENST00000417024.2 ENST00000578764.1 ENST00000582773.1 ENST00000582330.1 |
TMEM104
|
transmembrane protein 104 |
chrX_-_153775426 | 2.14 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
chr8_-_145050890 | 2.14 |
ENST00000436759.2
|
PLEC
|
plectin |
chr6_+_44095263 | 2.13 |
ENST00000532634.1
|
TMEM63B
|
transmembrane protein 63B |
chrX_+_148622138 | 2.12 |
ENST00000450602.2
ENST00000441248.1 |
CXorf40A
|
chromosome X open reading frame 40A |
chr22_+_38004942 | 2.12 |
ENST00000439161.1
ENST00000449944.1 ENST00000411501.1 ENST00000453208.1 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr7_-_1499123 | 2.12 |
ENST00000297508.7
|
MICALL2
|
MICAL-like 2 |
chr7_-_2883650 | 2.11 |
ENST00000544127.1
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12 |
chr6_+_44095347 | 2.11 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
chr2_+_241392227 | 2.11 |
ENST00000420138.1
|
GPC1
|
glypican 1 |
chr19_+_48972459 | 2.11 |
ENST00000427476.1
|
CYTH2
|
cytohesin 2 |
chr11_+_560956 | 2.11 |
ENST00000397582.3
ENST00000344375.4 ENST00000397583.3 |
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr14_-_20929624 | 2.10 |
ENST00000398020.4
ENST00000250489.4 |
TMEM55B
|
transmembrane protein 55B |
chr17_+_79935464 | 2.10 |
ENST00000581647.1
ENST00000580534.1 ENST00000579684.1 |
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
chr11_-_777467 | 2.09 |
ENST00000397472.2
ENST00000524550.1 ENST00000319863.8 ENST00000526325.1 ENST00000442059.2 |
PDDC1
|
Parkinson disease 7 domain containing 1 |
chr10_-_105615164 | 2.09 |
ENST00000355946.2
ENST00000369774.4 |
SH3PXD2A
|
SH3 and PX domains 2A |
chrX_+_152240819 | 2.09 |
ENST00000421798.3
ENST00000535416.1 |
PNMA6C
PNMA6A
|
paraneoplastic Ma antigen family member 6C paraneoplastic Ma antigen family member 6A |
chr7_+_99775520 | 2.09 |
ENST00000317296.5
ENST00000422690.1 ENST00000439782.1 |
STAG3
|
stromal antigen 3 |
chr11_+_117049445 | 2.09 |
ENST00000324225.4
ENST00000532960.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr19_+_4304685 | 2.09 |
ENST00000601006.1
|
FSD1
|
fibronectin type III and SPRY domain containing 1 |
chr22_-_19279201 | 2.08 |
ENST00000353891.5
ENST00000263200.10 ENST00000427926.1 ENST00000449918.1 |
CLTCL1
|
clathrin, heavy chain-like 1 |
chrX_-_152245978 | 2.08 |
ENST00000538162.2
|
PNMA6D
|
paraneoplastic Ma antigen family member 6D (pseudogene) |
chr8_+_27348626 | 2.08 |
ENST00000517536.1
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic |
chr11_-_64570624 | 2.08 |
ENST00000439069.1
|
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr16_+_2563871 | 2.07 |
ENST00000330398.4
ENST00000568562.1 ENST00000569317.1 |
ATP6V0C
ATP6C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c Uncharacterized protein |
chr19_+_42788172 | 2.07 |
ENST00000160740.3
|
CIC
|
capicua transcriptional repressor |
chr16_-_1429674 | 2.06 |
ENST00000403703.1
ENST00000397464.1 ENST00000402641.2 |
UNKL
|
unkempt family zinc finger-like |
chr19_-_53445819 | 2.06 |
ENST00000549216.1
|
ZNF816
|
zinc finger protein 816 |
chr22_-_19109901 | 2.05 |
ENST00000545799.1
ENST00000537045.1 ENST00000263196.7 |
DGCR2
|
DiGeorge syndrome critical region gene 2 |
chr22_+_45705987 | 2.05 |
ENST00000405673.1
|
FAM118A
|
family with sequence similarity 118, member A |
chr9_-_138799070 | 2.05 |
ENST00000389532.4
ENST00000409386.3 |
CAMSAP1
|
calmodulin regulated spectrin-associated protein 1 |
chr19_-_14117074 | 2.05 |
ENST00000588885.1
ENST00000254325.4 |
RFX1
|
regulatory factor X, 1 (influences HLA class II expression) |
chr16_+_29817399 | 2.04 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr19_+_49617581 | 2.04 |
ENST00000391864.3
|
LIN7B
|
lin-7 homolog B (C. elegans) |
chr19_-_49568311 | 2.04 |
ENST00000595857.1
ENST00000451356.2 |
NTF4
|
neurotrophin 4 |
chr2_+_109150887 | 2.04 |
ENST00000428064.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr1_-_21978312 | 2.04 |
ENST00000359708.4
ENST00000290101.4 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr19_-_47734448 | 2.04 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr19_+_50094866 | 2.03 |
ENST00000418929.2
|
PRR12
|
proline rich 12 |
chr22_+_22676808 | 2.03 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr11_+_6411636 | 2.02 |
ENST00000299397.3
ENST00000356761.2 ENST00000342245.4 |
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal |
chr11_-_12030681 | 2.02 |
ENST00000529338.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr1_-_21995794 | 2.01 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr11_+_47430133 | 2.00 |
ENST00000531974.1
ENST00000531419.1 ENST00000531865.1 ENST00000362021.4 ENST00000354884.4 |
SLC39A13
|
solute carrier family 39 (zinc transporter), member 13 |
chr19_+_14544099 | 2.00 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
chr19_+_17326191 | 1.99 |
ENST00000595101.1
ENST00000596136.1 ENST00000379776.4 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr19_-_39303576 | 1.99 |
ENST00000594209.1
|
LGALS4
|
lectin, galactoside-binding, soluble, 4 |
chr4_-_967326 | 1.98 |
ENST00000273814.3
|
DGKQ
|
diacylglycerol kinase, theta 110kDa |
chr21_-_45759250 | 1.98 |
ENST00000397956.3
ENST00000339818.4 ENST00000325223.7 |
C21orf2
|
chromosome 21 open reading frame 2 |
chr7_-_25219667 | 1.98 |
ENST00000444434.1
|
C7orf31
|
chromosome 7 open reading frame 31 |
chr19_+_47778119 | 1.98 |
ENST00000552360.2
|
PRR24
|
proline rich 24 |
chr14_+_105331596 | 1.98 |
ENST00000556508.1
ENST00000414716.3 ENST00000453495.1 ENST00000418279.1 |
CEP170B
|
centrosomal protein 170B |
chr7_+_97910981 | 1.98 |
ENST00000297290.3
|
BRI3
|
brain protein I3 |
chr17_+_6939362 | 1.97 |
ENST00000308027.6
|
SLC16A13
|
solute carrier family 16, member 13 |
chr21_+_47743995 | 1.97 |
ENST00000359568.5
|
PCNT
|
pericentrin |
chr11_+_68816356 | 1.96 |
ENST00000294309.3
ENST00000542467.1 |
TPCN2
|
two pore segment channel 2 |
chr1_-_1293904 | 1.96 |
ENST00000309212.6
ENST00000342753.4 ENST00000445648.2 |
MXRA8
|
matrix-remodelling associated 8 |
chr7_-_73153161 | 1.95 |
ENST00000395147.4
|
ABHD11
|
abhydrolase domain containing 11 |
chr16_+_2961910 | 1.95 |
ENST00000253928.9
|
FLYWCH1
|
FLYWCH-type zinc finger 1 |
chr1_-_52831796 | 1.95 |
ENST00000284376.3
ENST00000438831.1 ENST00000371586.2 |
CC2D1B
|
coiled-coil and C2 domain containing 1B |
chr16_-_4466565 | 1.94 |
ENST00000572467.1
ENST00000423908.2 ENST00000572044.1 ENST00000571052.1 |
CORO7-PAM16
CORO7
|
CORO7-PAM16 readthrough coronin 7 |
chr11_+_130184888 | 1.94 |
ENST00000602376.1
ENST00000532116.3 ENST00000602310.1 |
RP11-121M22.1
|
RP11-121M22.1 |
chr16_+_770975 | 1.94 |
ENST00000569529.1
ENST00000564000.1 ENST00000219535.3 |
FAM173A
|
family with sequence similarity 173, member A |
chr5_+_92228 | 1.93 |
ENST00000512035.1
|
CTD-2231H16.1
|
CTD-2231H16.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
1.6 | 4.9 | GO:0003192 | mitral valve formation(GO:0003192) |
1.4 | 1.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.3 | 5.2 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.3 | 3.8 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
1.1 | 1.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
1.1 | 4.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
1.1 | 3.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.1 | 3.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
1.1 | 3.2 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
1.1 | 3.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
1.1 | 3.2 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
1.1 | 6.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.0 | 3.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
1.0 | 6.9 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
1.0 | 2.0 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
1.0 | 2.9 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
1.0 | 1.0 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.9 | 2.8 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.9 | 5.6 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.9 | 3.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.9 | 2.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.9 | 0.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.9 | 3.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.9 | 2.7 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
0.9 | 0.9 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.9 | 7.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.9 | 4.3 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
0.9 | 0.9 | GO:0040031 | snRNA modification(GO:0040031) |
0.9 | 5.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.9 | 2.6 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.9 | 1.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.8 | 3.4 | GO:1903412 | response to bile acid(GO:1903412) |
0.8 | 7.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.8 | 2.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.8 | 1.7 | GO:1901656 | glycoside transport(GO:1901656) |
0.8 | 3.3 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.8 | 4.1 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.8 | 2.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.8 | 2.5 | GO:0044691 | tooth eruption(GO:0044691) |
0.8 | 4.1 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.8 | 2.4 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.8 | 2.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.8 | 2.4 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.8 | 3.2 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.8 | 2.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.8 | 2.3 | GO:0001300 | chronological cell aging(GO:0001300) |
0.8 | 3.8 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.8 | 3.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.8 | 2.3 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.8 | 0.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.8 | 2.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.8 | 4.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.7 | 9.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 2.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.7 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.7 | 4.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 2.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.7 | 2.2 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.7 | 2.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.7 | 7.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.7 | 4.3 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.7 | 2.1 | GO:0048627 | myoblast development(GO:0048627) |
0.7 | 2.9 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.7 | 2.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.7 | 1.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.7 | 2.1 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.7 | 0.7 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.7 | 2.1 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
0.7 | 2.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.7 | 2.8 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.7 | 6.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.7 | 2.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.7 | 2.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.7 | 2.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.7 | 4.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.7 | 0.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 1.4 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.7 | 0.7 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.7 | 0.7 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.7 | 2.0 | GO:0018012 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.7 | 2.0 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.7 | 0.7 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.7 | 0.7 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.7 | 0.7 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.7 | 1.3 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.7 | 1.3 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.7 | 2.0 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
0.7 | 6.0 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.7 | 2.6 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.7 | 3.9 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.6 | 2.6 | GO:0060032 | notochord regression(GO:0060032) |
0.6 | 1.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 4.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.6 | 2.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.6 | 3.2 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.6 | 0.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.6 | 1.9 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.6 | 0.6 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.6 | 3.8 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.6 | 4.4 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.6 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 2.5 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.6 | 0.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.6 | 4.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.6 | 1.9 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.6 | 1.8 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.6 | 1.8 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.6 | 1.8 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.6 | 2.4 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.6 | 4.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.6 | 1.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 0.6 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.6 | 1.8 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.6 | 4.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 1.8 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.6 | 1.8 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 0.6 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 5.3 | GO:0009644 | response to high light intensity(GO:0009644) |
0.6 | 4.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 2.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 2.3 | GO:0003335 | corneocyte development(GO:0003335) |
0.6 | 2.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.6 | 0.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.6 | 1.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.6 | 1.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.6 | 5.2 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.6 | 1.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.6 | 1.7 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.6 | 1.7 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.6 | 1.7 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.6 | 4.5 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
0.6 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.6 | 2.8 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.6 | 1.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.6 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.6 | 2.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.6 | 2.2 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.5 | 1.6 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.5 | 3.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 3.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 2.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.5 | 3.8 | GO:2000814 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.5 | 0.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.5 | 1.6 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.5 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.5 | 1.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.5 | 1.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.5 | 3.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.5 | 3.7 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.5 | 1.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.5 | 2.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 2.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.5 | 2.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 5.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 2.6 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.5 | 3.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.5 | 1.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.5 | 5.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.5 | 2.1 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.5 | 1.5 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.5 | 2.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.5 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 3.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.5 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 4.6 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
0.5 | 2.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.5 | 2.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.5 | 1.5 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.5 | 2.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 1.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.5 | 0.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.5 | 1.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 6.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 4.4 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 3.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.5 | 2.0 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.5 | 4.9 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.5 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.5 | 1.5 | GO:0021503 | neural fold bending(GO:0021503) |
0.5 | 2.4 | GO:0015862 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
0.5 | 3.4 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.5 | 1.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.5 | 2.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.5 | 0.5 | GO:2000532 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
0.5 | 6.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.5 | 1.4 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.5 | 1.9 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.5 | 2.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 0.5 | GO:0060022 | hard palate development(GO:0060022) |
0.5 | 0.5 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.5 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.5 | 7.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 1.4 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.5 | 1.9 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.5 | 0.5 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.5 | 3.2 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.5 | 2.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 1.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 2.3 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.5 | 2.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.5 | 1.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 0.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 3.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.5 | 2.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 1.8 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.4 | 4.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 1.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.4 | 3.6 | GO:0046618 | drug export(GO:0046618) |
0.4 | 1.3 | GO:1901207 | regulation of heart looping(GO:1901207) |
0.4 | 2.6 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.4 | 0.9 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.4 | 0.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 1.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 3.0 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.4 | 1.7 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.4 | 0.9 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.4 | 3.0 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.4 | 1.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.4 | 0.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 3.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.4 | 1.3 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.4 | 1.7 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.4 | 0.4 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.4 | 1.3 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.4 | 2.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.4 | 1.7 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.4 | 3.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 0.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.4 | 10.5 | GO:0030220 | platelet formation(GO:0030220) |
0.4 | 3.3 | GO:0015811 | L-cystine transport(GO:0015811) |
0.4 | 0.8 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.4 | 8.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.4 | 2.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 0.4 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.4 | 3.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.4 | 1.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.4 | 2.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.4 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 0.4 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
0.4 | 2.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 1.2 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.4 | 2.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 0.8 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.4 | 0.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 1.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 1.2 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.4 | 1.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 0.4 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 2.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.4 | 1.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.4 | 4.3 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.4 | 7.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 2.8 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.4 | 4.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 1.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.4 | 3.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 2.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 1.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.4 | 1.9 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.4 | 1.2 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.4 | 1.9 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 2.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 0.8 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.4 | 1.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.4 | 2.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 1.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 0.8 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.4 | 1.9 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.4 | 1.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.4 | 1.5 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.4 | 6.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 1.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.4 | 1.5 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.4 | 1.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.4 | 1.9 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.4 | 2.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 8.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.4 | 0.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.4 | 1.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.4 | 0.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.4 | 1.9 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.4 | 4.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.4 | 1.1 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.4 | 1.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.4 | 1.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.4 | 1.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 12.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.5 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 0.7 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.4 | 3.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 1.5 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.4 | 1.8 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.4 | 1.1 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.4 | 1.1 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.4 | 0.4 | GO:0003292 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.4 | 1.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.4 | 0.7 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 2.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 1.4 | GO:1905044 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.4 | 1.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 2.8 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.4 | 1.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.4 | 0.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 2.8 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 1.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.4 | 0.7 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.3 | 1.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.3 | 0.7 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 7.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.3 | 2.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 1.4 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.3 | 1.4 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.3 | 1.7 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 3.8 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 1.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.3 | 0.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.3 | 1.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.3 | 0.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 1.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 1.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.3 | 1.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.3 | 1.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 1.0 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.3 | 1.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 1.3 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 3.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 3.3 | GO:0061365 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.3 | 1.0 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.3 | 1.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 2.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 2.6 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.3 | 1.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.3 | 1.6 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
0.3 | 2.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 1.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.3 | 1.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.3 | 2.6 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 0.3 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 1.6 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.3 | 5.7 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.3 | 2.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 6.0 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.3 | 2.9 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.3 | 1.9 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 1.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 5.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 0.6 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.3 | 5.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 0.6 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.3 | 1.9 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.3 | 4.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.3 | 0.6 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 0.9 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.3 | 2.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.3 | 1.3 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.3 | 0.9 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.3 | 1.2 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.3 | 4.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 5.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.3 | 0.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.9 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 0.6 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 0.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 3.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 2.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.3 | 4.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 0.6 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 0.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.3 | 1.5 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.3 | 9.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.3 | 0.9 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.3 | 1.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 2.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 0.9 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.3 | 13.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 3.3 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 1.2 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.3 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.2 | GO:0090009 | primitive streak formation(GO:0090009) |
0.3 | 2.4 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.3 | 4.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.6 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 0.6 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.3 | 1.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.9 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.3 | 0.6 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.3 | 2.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 3.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 | 3.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 0.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.3 | 0.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 3.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 2.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 3.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.3 | 0.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 1.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.3 | 1.8 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.3 | 1.5 | GO:0032218 | riboflavin transport(GO:0032218) |
0.3 | 1.5 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.3 | 1.2 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.3 | 5.2 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
0.3 | 0.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 0.6 | GO:0097065 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.3 | 0.9 | GO:0019075 | virus maturation(GO:0019075) |
0.3 | 1.4 | GO:2000468 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
0.3 | 0.9 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.3 | 0.6 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.3 | 1.7 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.3 | 0.3 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 2.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 2.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 0.9 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.3 | 2.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.3 | 5.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 0.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.3 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
0.3 | 0.9 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.3 | 0.8 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.3 | 5.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 1.4 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 1.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.3 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.3 | 1.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.3 | 1.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 0.6 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.3 | 1.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 2.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 5.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 1.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.3 | 0.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 2.5 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.3 | 6.6 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.3 | 1.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 3.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 2.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.3 | 1.1 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.3 | 0.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 | 1.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.3 | 1.6 | GO:0000423 | macromitophagy(GO:0000423) |
0.3 | 0.8 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.3 | 3.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.5 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.3 | 3.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 1.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 2.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.3 | 5.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.3 | 3.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 1.1 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.3 | 2.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.3 | 1.1 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.3 | 1.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 6.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.3 | 4.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 4.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 2.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.3 | 3.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.6 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 0.3 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.3 | 0.3 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.3 | 2.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 1.0 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.3 | 0.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.3 | 1.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 1.0 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.3 | 1.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 1.3 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.3 | 1.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 3.9 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.3 | 0.8 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 0.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.3 | 2.0 | GO:0044211 | CTP salvage(GO:0044211) |
0.3 | 1.3 | GO:0001885 | endothelial cell development(GO:0001885) |
0.3 | 3.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.3 | 0.3 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.3 | 0.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 0.5 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.3 | 3.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 1.8 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.3 | 2.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 1.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 1.0 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.3 | 0.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.3 | 1.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 1.8 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 0.8 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.3 | 1.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.7 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.2 | 0.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.2 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.7 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.2 | 6.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.2 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.2 | 3.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.2 | 1.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.2 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.5 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.2 | 0.2 | GO:1905026 | positive regulation of actin filament-based movement(GO:1903116) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.2 | 5.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.5 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 1.0 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 4.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.2 | 2.9 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.2 | 1.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.2 | 1.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 11.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.2 | GO:1990910 | response to hypobaric hypoxia(GO:1990910) |
0.2 | 1.0 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.2 | 4.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 1.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.5 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 0.7 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 1.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.2 | GO:0021539 | subthalamus development(GO:0021539) |
0.2 | 0.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.4 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.2 | 1.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.7 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 0.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 1.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.5 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.2 | 1.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.2 | 1.2 | GO:0033590 | response to cobalamin(GO:0033590) |
0.2 | 0.9 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 1.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 2.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.7 | GO:0035623 | renal glucose absorption(GO:0035623) |
0.2 | 1.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 0.5 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.2 | 0.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.2 | 0.5 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 0.9 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 | 5.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.9 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.2 | 0.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 1.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.2 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.2 | 1.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 0.5 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.2 | 0.7 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.2 | 0.7 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.2 | 1.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 0.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 0.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 2.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 1.8 | GO:0007512 | adult heart development(GO:0007512) |
0.2 | 0.5 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.2 | 2.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 1.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 1.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.2 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 3.1 | GO:0051154 | negative regulation of striated muscle cell differentiation(GO:0051154) |
0.2 | 6.1 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.2 | 0.7 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.2 | 0.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 3.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.2 | 0.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 1.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 1.3 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.2 | 0.7 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.2 | 3.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 0.7 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.9 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 2.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.5 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.2 | 0.7 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 6.5 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.2 | 2.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 1.9 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 2.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 3.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.6 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 2.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.3 | GO:0021592 | fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
0.2 | 0.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.9 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.2 | 1.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 1.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 2.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.2 | 3.4 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 1.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 0.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.0 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 0.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 2.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.4 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.2 | 1.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 1.7 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.2 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.8 | GO:0002384 | hepatic immune response(GO:0002384) |
0.2 | 2.1 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.2 | 3.7 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.2 | 3.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 2.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.2 | 0.6 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
0.2 | 3.7 | GO:0014870 | response to muscle inactivity(GO:0014870) |
0.2 | 0.8 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.2 | 1.6 | GO:0006751 | glutathione catabolic process(GO:0006751) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 1.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 1.6 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 2.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 1.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 4.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 7.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 1.8 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 0.8 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.2 | 1.2 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.2 | 1.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.2 | 0.6 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.2 | 0.8 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 1.8 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.2 | 0.2 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) response to fluoride(GO:1902617) |
0.2 | 10.6 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.2 | 0.4 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.4 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.2 | 1.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 4.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.8 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 2.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.8 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 3.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 5.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 0.8 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) positive regulation of opsonization(GO:1903028) |
0.2 | 1.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.2 | 1.0 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 1.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.8 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.2 | 1.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.4 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
0.2 | 1.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 1.0 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.8 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.2 | GO:1901907 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.2 | 2.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.4 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.2 | 0.4 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.2 | 3.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 0.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 4.4 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.2 | 0.4 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.2 | 2.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.2 | 4.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.8 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.2 | 0.8 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.2 | 1.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 1.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.2 | 0.6 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.2 | 0.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.4 | GO:0072338 | cellular lactam metabolic process(GO:0072338) |
0.2 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 0.4 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.2 | 0.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.2 | 0.4 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.2 | 1.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.2 | 0.6 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.2 | 2.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.7 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.2 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 1.3 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 1.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.2 | 0.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.2 | 2.6 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.2 | 0.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.2 | 1.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 1.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.6 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.6 | GO:0072177 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
0.2 | 0.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.4 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.9 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.2 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 2.2 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.9 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 3.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.1 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.2 | 1.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 3.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.2 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 2.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.9 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.2 | 1.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.2 | 0.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 2.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 2.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 3.2 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 2.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.2 | 0.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 3.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 1.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 1.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 1.4 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 0.2 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.2 | 1.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 1.0 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.2 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.2 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 1.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.9 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.5 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.3 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.2 | 1.2 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.2 | 1.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 2.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.2 | 0.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.5 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 1.0 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 0.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 3.1 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.2 | 2.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 1.5 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
0.2 | 1.7 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 8.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.2 | 0.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.2 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.3 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.2 | 0.5 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.2 | 3.7 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.2 | 1.0 | GO:0051958 | methotrexate transport(GO:0051958) |
0.2 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.7 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.2 | 3.1 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 2.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.3 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 1.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 3.4 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 2.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.3 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.2 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.6 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
0.2 | 5.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 | 4.0 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 1.6 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.2 | 0.5 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.6 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.2 | 0.5 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 0.6 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 2.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 3.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.5 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 2.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 0.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 2.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.3 | GO:0097187 | dentinogenesis(GO:0097187) |
0.2 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 2.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.6 | GO:0060849 | radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.2 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.5 | GO:0048066 | developmental pigmentation(GO:0048066) |
0.2 | 1.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 2.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.2 | 0.9 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 0.2 | GO:0021648 | cranial nerve formation(GO:0021603) vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
0.2 | 1.1 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.8 | GO:0061074 | regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 1.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 2.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.1 | 0.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 1.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.2 | GO:0061589 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 2.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 2.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 1.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.4 | GO:0046822 | regulation of nucleocytoplasmic transport(GO:0046822) |
0.1 | 0.7 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.7 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.6 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.1 | 1.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 0.7 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 1.3 | GO:0048864 | stem cell development(GO:0048864) |
0.1 | 1.6 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 1.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.1 | 0.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.1 | 0.6 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 | 1.2 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 1.3 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 1.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 3.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.3 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.1 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 1.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 2.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.7 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 2.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.6 | GO:0021678 | third ventricle development(GO:0021678) |
0.1 | 1.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.4 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 3.8 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 1.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 1.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.4 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 | 1.1 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.1 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 1.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 1.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.1 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 0.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 1.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.4 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.8 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.7 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.4 | GO:1900920 | regulation of amino acid import(GO:0010958) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.1 | 2.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 7.4 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 2.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 1.9 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.1 | 0.8 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 1.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 4.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 4.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.4 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.8 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.8 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 3.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 1.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.9 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 4.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.7 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 1.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.3 | GO:0034059 | response to anoxia(GO:0034059) |
0.1 | 1.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 1.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.6 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 1.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 1.0 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 0.4 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 1.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 1.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.3 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.1 | 0.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 1.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.1 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.1 | 0.1 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 2.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.6 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.1 | 0.3 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 3.9 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 1.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.1 | 0.5 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 1.9 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 1.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 1.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 1.9 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 1.0 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.2 | GO:0097107 | postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 0.5 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 2.9 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 1.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 1.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 1.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.6 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.5 | GO:0032108 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.1 | 0.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 3.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 3.9 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.5 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.3 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 0.9 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 3.7 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 1.6 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.6 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 1.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.8 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.1 | 0.6 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 2.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.1 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.1 | 2.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 1.6 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.1 | 0.5 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 0.5 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.8 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.8 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 1.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.6 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.1 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.7 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.8 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 1.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 4.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 1.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 0.4 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 2.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.1 | 0.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 1.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 1.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.4 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.3 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 2.9 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.1 | 0.4 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.5 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 1.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.9 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 1.9 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.1 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 8.4 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.8 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 4.7 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.1 | 0.5 | GO:0008295 | spermidine metabolic process(GO:0008216) spermidine biosynthetic process(GO:0008295) |
0.1 | 2.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 8.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 1.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.8 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 1.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.5 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 1.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 3.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 2.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 2.9 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.1 | 0.2 | GO:0098773 | skin epidermis development(GO:0098773) |
0.1 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 1.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 4.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.6 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.9 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 2.9 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.3 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.1 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.1 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.8 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 2.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0019516 | lactate oxidation(GO:0019516) |
0.1 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 6.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.5 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.1 | 0.2 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
0.1 | 0.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 2.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0001656 | metanephros development(GO:0001656) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.4 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.6 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.6 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.9 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 1.0 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 3.0 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 5.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 1.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.9 | GO:0015824 | proline transport(GO:0015824) |
0.1 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 3.0 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.1 | 0.5 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.3 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.1 | 0.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.5 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 2.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.2 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.1 | 1.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 1.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 2.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 1.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 1.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.1 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.1 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 2.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 1.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 0.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.6 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.1 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
0.1 | 1.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) regulation of immunological synapse formation(GO:2000520) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
0.1 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 1.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.2 | GO:0071529 | cementum mineralization(GO:0071529) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.3 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.2 | GO:0070169 | positive regulation of biomineral tissue development(GO:0070169) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.8 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.4 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.3 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 2.5 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 1.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.1 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 1.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.9 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 1.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.6 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.6 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 1.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 1.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 0.1 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.4 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.2 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 1.3 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.3 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 0.3 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.3 | GO:0090218 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.5 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.1 | 0.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.1 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.1 | 1.0 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 0.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 1.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 1.0 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.3 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.3 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.1 | 0.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.9 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.7 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.4 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.4 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.1 | 0.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.3 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.1 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.3 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.3 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.3 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.1 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.5 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.2 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 2.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.1 | 1.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.2 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.6 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.2 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:0042092 | type 2 immune response(GO:0042092) |
0.1 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.8 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.1 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
0.1 | 8.8 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.1 | 1.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.1 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.1 | 0.3 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.8 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.1 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.1 | 0.2 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.5 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.1 | 0.4 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 1.8 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 1.2 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.1 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.0 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.0 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 1.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.1 | GO:1903911 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
0.0 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 3.8 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.2 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.6 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 1.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.0 | 0.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 4.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.9 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.0 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.3 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.0 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 0.4 | GO:1902746 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 1.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.9 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.0 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.1 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.0 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.0 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.0 | 0.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.1 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.0 | 0.0 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.0 | 0.2 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.0 | 0.0 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.0 | 0.0 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.8 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.2 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.0 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 6.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.1 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.2 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.6 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.4 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.3 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.0 | 0.5 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 2.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.0 | 2.2 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.0 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.0 | 0.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 1.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.5 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.0 | 0.5 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.2 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.2 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.2 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.0 | 0.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.4 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.3 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.2 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 2.7 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.5 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.0 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 1.8 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.0 | 1.6 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.0 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.0 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 1.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 1.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.0 | 0.7 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.0 | GO:0072235 | metanephric distal tubule development(GO:0072235) |
0.0 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.1 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.3 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 1.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.2 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.0 | 0.4 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.0 | 0.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.0 | GO:0072044 | collecting duct development(GO:0072044) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.0 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.0 | 0.0 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.0 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.0 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.0 | 0.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 1.8 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.0 | 0.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.0 | 0.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0009624 | defense response to nematode(GO:0002215) response to nematode(GO:0009624) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0010171 | body morphogenesis(GO:0010171) |
0.0 | 0.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.0 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.1 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.4 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.0 | 0.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.3 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.0 | 0.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.0 | 0.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.0 | 0.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.2 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.1 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.0 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.0 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.0 | GO:0002064 | epithelial cell development(GO:0002064) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:0006096 | glycolytic process(GO:0006096) |
0.0 | 0.0 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.4 | 5.5 | GO:0043293 | apoptosome(GO:0043293) |
1.3 | 8.1 | GO:0071797 | LUBAC complex(GO:0071797) |
1.3 | 5.3 | GO:0031523 | Myb complex(GO:0031523) |
1.3 | 5.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
1.2 | 7.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.1 | 3.2 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.9 | 0.9 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.8 | 4.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.8 | 3.2 | GO:0045160 | myosin I complex(GO:0045160) |
0.8 | 3.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.7 | 2.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 3.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 4.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.7 | 4.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.7 | 3.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 3.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.6 | 5.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.6 | 2.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.6 | 2.8 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.5 | 1.6 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.5 | 7.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 2.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 3.6 | GO:0042825 | TAP complex(GO:0042825) |
0.5 | 2.6 | GO:0002133 | polycystin complex(GO:0002133) |
0.5 | 1.0 | GO:0019034 | viral replication complex(GO:0019034) |
0.5 | 3.0 | GO:0032021 | NELF complex(GO:0032021) |
0.5 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 2.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 2.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.5 | 0.5 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.5 | 1.9 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.5 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.5 | 7.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.5 | 1.4 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.5 | 2.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.8 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.5 | 2.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.4 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 2.2 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.4 | 4.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 3.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 2.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 1.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.4 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 2.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.4 | 1.6 | GO:0044301 | climbing fiber(GO:0044301) |
0.4 | 2.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 1.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 6.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 2.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 1.9 | GO:0036398 | TCR signalosome(GO:0036398) |
0.4 | 1.1 | GO:0000806 | Y chromosome(GO:0000806) |
0.4 | 1.9 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.4 | 2.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 5.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 3.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.4 | 3.0 | GO:0097361 | CIA complex(GO:0097361) |
0.4 | 3.7 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 2.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.4 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.4 | 1.8 | GO:0016938 | kinesin I complex(GO:0016938) |
0.3 | 1.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.3 | 1.0 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.3 | 4.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 4.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 2.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 2.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 2.0 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.3 | 1.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.3 | 3.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 7.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 1.3 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.3 | 2.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 4.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 8.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 5.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 2.5 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 0.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 0.3 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
0.3 | 3.4 | GO:0098574 | cytoplasmic side of late endosome membrane(GO:0098560) cytoplasmic side of lysosomal membrane(GO:0098574) |
0.3 | 0.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 18.5 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.9 | GO:0034657 | GID complex(GO:0034657) |
0.3 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 6.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 0.6 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.3 | 0.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 1.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 1.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 0.9 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.3 | 0.9 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.3 | 1.4 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.3 | 2.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 2.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 2.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 0.8 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 0.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 1.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 1.1 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.3 | 2.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 0.8 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.3 | 2.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 3.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.8 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.3 | 0.8 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 2.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 1.1 | GO:0044753 | amphisome(GO:0044753) |
0.3 | 1.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 2.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.3 | 3.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 4.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 4.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 2.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 1.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.3 | 0.8 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.3 | 2.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 0.3 | GO:0098793 | presynapse(GO:0098793) |
0.2 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.2 | 0.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.2 | 1.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 3.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 0.2 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.2 | 0.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.0 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.2 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.2 | 1.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 3.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 1.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 1.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 21.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 5.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 7.5 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.7 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.2 | 0.9 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 1.1 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 1.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.2 | 1.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 1.4 | GO:0032044 | DSIF complex(GO:0032044) |
0.2 | 1.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.8 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 5.8 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 6.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 1.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 6.9 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 13.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 4.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 2.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 1.7 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.9 | GO:1990745 | EARP complex(GO:1990745) |
0.2 | 1.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 2.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 5.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.8 | GO:0036027 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.2 | 3.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 5.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 0.4 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.2 | 2.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 1.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 3.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 5.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 1.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 31.7 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 5.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 6.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 1.4 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.2 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
0.2 | 8.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 3.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 4.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.6 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 2.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.6 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.2 | 1.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.5 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 1.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 4.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.2 | 28.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.8 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 2.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 4.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 1.0 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 2.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 3.4 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 2.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 2.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 2.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.7 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 12.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 2.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 1.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 4.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 1.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 2.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.8 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.2 | 5.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 1.0 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 4.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 3.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 1.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.3 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.6 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.1 | 5.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.7 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 3.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 4.9 | GO:0031430 | M band(GO:0031430) |
0.1 | 3.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 1.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 9.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 2.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 2.3 | GO:0098589 | membrane region(GO:0098589) |
0.1 | 2.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 2.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.7 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 1.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.7 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 3.3 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.4 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 7.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 7.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.2 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 3.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 3.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 3.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 3.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 1.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.1 | 1.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 2.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 2.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 2.7 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.7 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.5 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 15.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 5.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 3.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 1.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 2.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 1.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.2 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 7.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 0.5 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 5.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 1.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.9 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 1.4 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 0.6 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.7 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 0.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 13.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 0.3 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.1 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 11.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 8.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 6.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 9.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 2.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 0.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.7 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 4.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.8 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 3.1 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 2.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 6.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 4.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.2 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 2.1 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.1 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 5.1 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 2.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.3 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.1 | 1.5 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 2.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 2.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.2 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.1 | GO:0070160 | tricellular tight junction(GO:0061689) occluding junction(GO:0070160) |
0.1 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.4 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 7.5 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 36.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 8.8 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.7 | GO:0032797 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 0.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 2.6 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 19.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 5.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 3.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 9.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.2 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 1.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 9.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 1.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.7 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.1 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 2.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
0.0 | 10.9 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 4.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 24.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 2.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 2.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 12.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 2.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.0 | GO:0035101 | FACT complex(GO:0035101) |
0.0 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.1 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.0 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 17.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 3.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.5 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.0 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 10.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 1.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 10.3 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 1.3 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 2.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 11.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 3.2 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 6.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 2.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 1.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 3.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.1 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.0 | 0.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 3.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 49.0 | GO:0016021 | integral component of membrane(GO:0016021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
1.3 | 5.2 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
1.3 | 3.9 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
1.2 | 3.5 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.1 | 3.4 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
1.1 | 2.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.1 | 9.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.0 | 5.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.0 | 10.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
1.0 | 5.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
1.0 | 3.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.0 | 4.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.9 | 2.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.9 | 2.8 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.9 | 2.8 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.9 | 2.8 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.9 | 2.7 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
0.9 | 4.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.8 | 2.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.8 | 3.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.8 | 2.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.8 | 4.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 4.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.8 | 0.8 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
0.8 | 2.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.7 | 3.7 | GO:0070905 | serine binding(GO:0070905) |
0.7 | 2.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.7 | 2.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.7 | 2.9 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.7 | 2.2 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.7 | 5.7 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.7 | 4.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 3.4 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.7 | 2.0 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.7 | 2.0 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.7 | 15.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 2.0 | GO:0032093 | SAM domain binding(GO:0032093) |
0.7 | 2.0 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.7 | 2.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.6 | 5.8 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 1.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.6 | 3.2 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.6 | 1.9 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.6 | 4.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.6 | 2.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 1.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.6 | 2.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 2.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.6 | 1.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 1.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.6 | 1.8 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.6 | 3.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.6 | 3.0 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.6 | 2.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.6 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 3.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.6 | 2.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.6 | 2.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.6 | 1.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.6 | 2.3 | GO:0004803 | transposase activity(GO:0004803) |
0.6 | 1.7 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.6 | 15.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 0.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.6 | 2.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 1.7 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.6 | 0.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.6 | 3.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 3.9 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.6 | 2.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.6 | 2.2 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) leukotriene receptor activity(GO:0004974) |
0.5 | 3.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.6 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.5 | 2.2 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.5 | 5.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.5 | 2.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.5 | 1.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.5 | 1.6 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.5 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.5 | 1.5 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.5 | 2.6 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.5 | 2.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 3.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.5 | 1.5 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.5 | 1.5 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.5 | 5.4 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.5 | 2.0 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.5 | 2.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 2.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 1.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.5 | 1.9 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.5 | 1.4 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.5 | 4.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 6.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 1.8 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.5 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 3.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 4.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.3 | GO:0052825 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.4 | 8.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 5.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.4 | 2.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 2.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 1.3 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.4 | 3.0 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.4 | 1.7 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.4 | 2.6 | GO:1903135 | cupric ion binding(GO:1903135) |
0.4 | 0.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.4 | 1.3 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.4 | 4.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.4 | 3.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 1.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 1.3 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.4 | 2.1 | GO:0042806 | fucose binding(GO:0042806) |
0.4 | 2.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.4 | 4.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 2.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 0.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 2.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.6 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.4 | 0.8 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.4 | 1.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.4 | 2.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.4 | 1.9 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.4 | 7.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 2.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.4 | 3.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 1.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.4 | 3.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.9 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.4 | 1.5 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.4 | 1.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.4 | 3.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 3.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.4 | 1.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 1.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 2.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.4 | 4.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.4 | 1.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.4 | 0.7 | GO:0070026 | nitric oxide binding(GO:0070026) |
0.4 | 3.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.4 | 1.1 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.4 | 1.8 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.4 | 4.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.4 | 1.1 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.4 | 1.8 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.4 | 4.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 5.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.3 | 1.0 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.3 | 6.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 3.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 3.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.3 | 2.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 4.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 5.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 1.0 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.3 | 2.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.3 | 2.7 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.3 | 1.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.3 | 2.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.3 | 4.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 1.7 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.3 | 1.3 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.3 | 1.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 2.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.3 | 2.3 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.3 | 0.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 1.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.3 | 1.0 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.3 | 3.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 4.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 3.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 3.2 | GO:0005497 | androgen binding(GO:0005497) |
0.3 | 7.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 5.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 4.7 | GO:0003909 | DNA ligase activity(GO:0003909) |
0.3 | 4.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 0.6 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.3 | 0.6 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.3 | 0.9 | GO:0031403 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
0.3 | 2.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.3 | 0.9 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 2.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 3.7 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 3.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 2.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 1.2 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 1.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.3 | 2.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.3 | 10.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 3.9 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.3 | 0.9 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.3 | 0.9 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.3 | 0.9 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.3 | 1.8 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 1.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 7.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.3 | 10.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 2.4 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 6.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 3.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 1.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.3 | 5.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 4.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 2.3 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 2.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 6.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 4.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.4 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.3 | 1.7 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.3 | 1.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 5.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 2.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 2.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 3.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 0.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.3 | 2.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 0.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 6.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 1.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 0.8 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 8.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 6.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 3.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 2.5 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.3 | 3.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.4 | GO:0010736 | serum response element binding(GO:0010736) |
0.3 | 6.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.3 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 6.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 2.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 2.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.3 | 1.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 0.8 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.3 | 0.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.3 | 0.5 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.3 | 2.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 0.8 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.3 | 1.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.3 | 1.3 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.3 | 1.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 4.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 1.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 0.8 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.3 | 2.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 0.8 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.3 | 0.3 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 2.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 2.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.2 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 2.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 1.0 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.2 | 1.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.2 | 6.1 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.2 | 2.4 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 2.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 10.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 2.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 2.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 1.9 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 1.0 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 1.4 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 1.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 8.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 8.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.2 | 1.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 3.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.2 | 3.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 19.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 2.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 1.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 5.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.2 | 5.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.7 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.2 | 1.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.7 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.2 | 1.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 0.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.9 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.2 | 4.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 6.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.7 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.2 | 3.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 1.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.2 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 4.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.6 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.2 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.4 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.2 | 0.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.2 | 0.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.2 | 3.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 5.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 12.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 1.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 1.9 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 0.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.4 | GO:0090541 | MIT domain binding(GO:0090541) |
0.2 | 1.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 2.7 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 9.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 3.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 0.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 1.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 1.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 1.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.8 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 3.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 2.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.2 | GO:0034432 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.2 | 0.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 4.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.8 | GO:0004325 | ferrochelatase activity(GO:0004325) |
0.2 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.2 | 0.6 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.2 | 0.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.2 | 2.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 7.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 4.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.2 | 0.6 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.2 | 0.7 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.2 | 1.1 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 5.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.2 | 0.7 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.2 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 8.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.5 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 2.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 4.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.2 | 0.5 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.2 | 0.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.2 | 3.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 1.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 1.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 10.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 1.4 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 0.5 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.2 | 2.5 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 1.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.5 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.2 | 4.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 2.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 0.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.2 | 0.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 2.0 | GO:0016502 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.5 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 1.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 3.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.3 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.2 | 1.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.2 | 1.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 0.5 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.2 | 1.0 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.2 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 1.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 8.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 4.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.5 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.2 | 1.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.2 | 4.4 | GO:0071949 | FAD binding(GO:0071949) |
0.2 | 1.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.5 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.8 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 0.8 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.2 | 1.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 4.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.2 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 0.6 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 2.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 3.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 2.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 1.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.4 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 4.3 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 1.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 2.0 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 7.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 4.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 3.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 2.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.7 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 1.6 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.9 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 2.3 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.1 | 0.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.1 | 4.6 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 35.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 2.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.4 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 4.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.5 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 7.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 4.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 2.4 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.8 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 1.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 1.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 1.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.8 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 1.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 4.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 5.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.3 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.1 | 1.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.9 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.1 | 2.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.1 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 1.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.3 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 0.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 2.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.5 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 2.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.3 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 3.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.4 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.1 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.2 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 4.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 0.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 3.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 1.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.1 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.5 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 2.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 2.1 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.3 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.1 | 0.4 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 5.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.6 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 2.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 2.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 4.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.1 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 3.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 3.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 3.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.4 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0008124 | phenylalanine 4-monooxygenase activity(GO:0004505) 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 3.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 2.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 6.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.9 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 3.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.1 | 0.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 3.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 1.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 1.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.2 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
0.1 | 1.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 52.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 11.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 1.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.3 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 1.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.9 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 3.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 4.4 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 2.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0072545 | tyrosine binding(GO:0072545) |
0.1 | 9.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 1.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.0 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.1 | 0.2 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 3.4 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 5.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 1.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.1 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.1 | 0.2 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.1 | 0.2 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.1 | 3.2 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.1 | 2.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.7 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 4.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 1.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 2.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 6.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 24.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 2.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) |
0.1 | 0.6 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.3 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.5 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 5.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 3.3 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.1 | 2.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 2.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.8 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.1 | 12.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 2.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 1.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 1.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.0 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.0 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 1.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 1.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.0 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 2.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.2 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.0 | 3.4 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 2.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.1 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.0 | 0.7 | GO:0030228 | low-density lipoprotein receptor activity(GO:0005041) lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.7 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.0 | 0.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 2.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 2.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 1.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0016882 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) cyclo-ligase activity(GO:0016882) |
0.0 | 0.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.0 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.0 | 1.3 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
0.0 | 0.1 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 5.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.6 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.3 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.0 | 7.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0052812 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.0 | 0.3 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.0 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.0 | 2.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.1 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.0 | 1.8 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 4.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.1 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 6.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 13.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 18.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 1.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 7.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 19.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 8.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 30.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 4.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 3.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 10.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 2.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 9.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 20.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 1.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 2.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 13.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 8.0 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 2.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 14.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 8.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 6.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 2.0 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 9.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 10.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 3.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 7.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 5.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 8.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 9.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 5.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 16.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 4.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 4.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 4.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 8.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 10.1 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 6.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 14.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 9.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 8.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 10.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 2.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 7.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 9.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 9.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 4.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 19.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 4.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 2.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 4.5 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 2.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 3.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 4.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 11.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.5 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 2.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 2.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 0.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 1.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 8.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.4 | 11.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 15.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 4.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 15.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 10.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 9.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 2.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.3 | 1.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 15.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 18.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 3.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 1.4 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.2 | 4.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 21.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 4.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 3.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 2.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 4.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 10.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 4.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 2.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 4.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 5.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 6.7 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.2 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 3.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 7.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 6.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 6.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 7.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 8.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 1.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 11.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 8.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.9 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 3.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 17.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 5.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 3.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 5.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 4.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 2.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 1.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 4.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 4.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 6.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 2.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 5.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.3 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.1 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 3.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.7 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 1.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 13.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.0 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 2.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 3.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 21.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 2.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 3.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 13.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 3.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 3.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 11.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 12.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 9.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 3.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 3.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 4.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 2.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.7 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 5.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 6.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 2.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 4.0 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
0.1 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 0.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 1.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 3.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 2.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 12.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 3.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 2.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 2.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 4.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 4.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 7.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 1.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 1.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 6.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 4.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 3.3 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 1.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |